Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging

NCT02266966 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.

NCT NCT02266966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02266966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging
Lead sponsor
Pierre Fabre Medicament
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
September 30, 2014
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subject